Literature DB >> 3126044

alpha-Glucosidase deficiency (Pompe's disease).

J M Tager1, R P Oude Elferink, A Reuser, M Kroos, L A Ginsel, J A Fransen, J Klumperman.   

Abstract

alpha-Glucosidase is deficient (less than 30% of control) in Pompe's disease, but the extent of the deficiency does not always correlate with the severity of the clinical symptoms. The defects that lead to a deficiency of alpha-glucosidase include synthesis of catalytically inactive protein, absence of mRNA for the enzyme, decreased synthesis of the precursor, lack of phosphorylation of the precursor, impaired conversion of the precursor to the mature enzyme and synthesis of unstable precursor. A single type of defect can lead to different clinical phenotypes. The precursor of alpha-glucosidase is present in the brush border of the polarized epithelial cells of small intestine and kidney and is secreted into urine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3126044     DOI: 10.1159/000469217

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  3 in total

1.  Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele.

Authors:  N Zhong; F Martiniuk; S Tzall; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

2.  Acid alpha-glucosidase deficiency: identification and expression of a missense mutation (S529V) in a Japanese adult phenotype.

Authors:  H Tsunoda; T Ohshima; J Tohyama; M Sasaki; N Sakuragawa; F Martiniuk
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

3.  Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening.

Authors:  Shelly Goomber; Erin Huggins; Catherine W Rehder; Jennifer L Cohen; Deeksha S Bali; Priya S Kishnani
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.